Pfizer Inc., University of California, San Francisco (UCSF) Expands Pact to Develop Small Molecule Drugs
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Drugmaker Pfizer Inc. said it is expanding its Centers for Therapeutic Innovation into the development of small-molecule drug candidates through a partnership with the University of California, San Francisco. Roughly two years ago, Pfizer opened the Boston Centers for Therapeutic Innovation, or CTI, an entrepreneurial network of partnerships with leading academic medical centers. The hope is that these partnerships will reduce the time and cost of drug discovery and development. Boston is also the global headquarters for the CTI network, which has established partnerships in New York City, San Francisco, and San Diego. Pfizer has roughly 2,100 employees in Massachusetts, most of them in either Andover or Cambridge.
Help employers find you! Check out all the jobs and post your resume.
Drugmaker Pfizer Inc. said it is expanding its Centers for Therapeutic Innovation into the development of small-molecule drug candidates through a partnership with the University of California, San Francisco. Roughly two years ago, Pfizer opened the Boston Centers for Therapeutic Innovation, or CTI, an entrepreneurial network of partnerships with leading academic medical centers. The hope is that these partnerships will reduce the time and cost of drug discovery and development. Boston is also the global headquarters for the CTI network, which has established partnerships in New York City, San Francisco, and San Diego. Pfizer has roughly 2,100 employees in Massachusetts, most of them in either Andover or Cambridge.
Help employers find you! Check out all the jobs and post your resume.